The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Natus Neurology sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Natus Neurologyorporated is a medical equipment company that provides neurological diagnosis and monitoring devices. It offers medical devices, software, supplies and services for the diagnosis, monitoring, and treatment of impairments and disorders effecting the brain, neural pathways, and eight sensory nervous systems. Its product portfolio includes PSG polysomnography devices, intracranial pressure and temperature monitors, catheters for the ICP monitor, EEG Software, hearing assessment software, balance assessment devices, hearing aid, and ophthalmic imaging systems among others. Its products are used by medical professionals in university medical centers, hospitals, private practices, clinics and research laboratories worldwide. Natus is headquartered in Middleton, Wisconsin, the US.
The key metrics of Natus Neurology related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As Natus Neurology is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Natus Neurology.
For a detailed understanding of the performance of Natus Neurology, buy the report here.